▶ Full Post Text
NICE (NICE) reported a beat in early August and the stock dropped 7%. AI ARR is up 52% to $362M, backlog is growing 72%, and management is buying back stock aggressively. The market still prices the whole thing at around 11x cash flow. I think that's wrong, and here's the work.
## What they do
NICE is the leading cloud platform for customer experience and contact center operations. When you call a bank, an airline, or the UK tax authority, there's a good chance NICE's CXone platform is routing, transcribing, and now running the AI agent on the other end. Their big product push is Cognigy, an AI agent engine they acquired and are integrating natively into CXone. Roughly 78% of revenue is now cloud.
The economics are asset light. CapEx averages about 3.5% of revenue. The real investment is R&D, which gets expensed.
## The setup
On August 5, NICE reported Q2: $782M revenue and $2.70 non-GAAP EPS, beating on both lines. Cloud revenue grew 12.6%, AI ARR hit $362M, up 52%. The stock fell over 7% anyway. The panic was about operating margin, which compressed to 25.3% in the quarter, plus the usual AI-disruption narrative.
Wall Street is terrified that cheap AI startups will make contact center software obsolete. Meanwhile NICE just signed its largest deal ever with HMRC, the UK tax authority, and AI backlog is up 72%. Enterprises don't hand their customer data and compliance workflows to untested startups. They buy the platform that already runs their operations, and the AI comes embedded in it.
## Cash flow
| Line | Amount |
|---|---|
| Operating Cash Flow | $615.92M |
| Less: Stock-Based Comp | -$139.16M |
| Working Capital Change | +$238.35M |
| Less: Smoothed CapEx (5yr avg) | -$106.52M |
| Less: Working Capital Reinvest | -$2.02M |
| **Cash Flow** | **$606.57M** |
| **Per Share (60.43M diluted)** | **$10.04** |
I use smoothed CapEx instead of the raw number because the annual figure swings with cloud infrastructure timing. The working capital addback gets normalized the same way.
Quality on top of that: 106% cloud net revenue retention, 18.4% seven-year compound growth in per-share cash flow, and roughly 6% annual share count reduction.
## Balance sheet and capital allocation
| Line | Amount |
|---|---|
| Net Cash | $224.16M |
| Total Debt | $86.08M |
| Net Cash Per Share | $3.71 |
| Market Cap | ~$6.05B |
The debt is essentially all leases. NICE paid off its $460M convertible notes in 2025. Management spent $528M on buybacks last year and $311M in the first half of 2026, shrinking shares about 6%. At a price that far below intrinsic value, that's intelligent capital allocation.
## Valuation
| Line | Amount |
|---|---|
| Cash Flow Per Share | $10.04 |
| Conservative Multiple | 20x |
| Business Value | $200.80 |
| Net Cash Per Share | $3.71 |
| **Intrinsic Value** | **$200.80** |
| Current Price | $101.85 |
| **Margin of Safety** | **~49%** |
A 20x multiple for a business compounding per-share cash flow at high teens with 106% retention is not heroic, it's fair for this level of predictability. Even at 15x the business alone is worth $150.60, still 49% above the current price. The market is paying 11x for the cash flows and giving zero credit for the AI revenue that is growing 52%.
## What would make me sell
The lag between record AI bookings and recognized revenue. Customers are signing, then taking a measured approach on data and governance before full deployment. If that gap widens to the point where backlog growth stalls, the bull case breaks. I'd also sell if the buyback program stops while the stock sits this far below intrinsic value.
## Where I land
I hold a position. This is a compounder with a fortress balance sheet, priced as a stagnant survivor during an AI panic. The AI integration is working, the cash flows are real, and management is acting like owners. Not financial advice, just my reasoning.
*Disclosure: I hold a position in NICE. Hard data from filings, AI-assisted writing, personal review and position. This is not financial advice.* https://youtu.be/-NMtM-50R6A?is=fcP65GE2NIQ841ju